Modular Medical Inc
Modular Medical Inc is a medical equipment and supplies company that provides modular solutions for healthcare facilities, primarily generating revenue through the sale of its products and services.
Business. Modular Medical Inc (MODD.O) is a healthcare services and equipment company that operates within the medical equipment, supplies, and distribution industry. The firm primarily engages in the sale of medical products, focusing on capital equipment and consumables for healthcare providers. Modular Medical is headquartered in the United States and is listed on the NASDAQ stock exchange. Specific details regarding operating segments or geographic revenue breakdowns are not provided in the available data.
At a glance
What drives this business
The watch-list the newsroom runs for this company — derived from its sector path, sharpened layer by layer. Not investment advice.
News & coverage
0Sector rotation
Developing storylines
Analysis
AI analysisOpportunity
Upcoming catalysts
Scheduled public events. Informational only — not investment advice.
- Company
- EarningsQ2 2026 earnings (expected)2026-10-28 · estimated
- Macro
- Rate decisionBank of England rate decision (press conf.)2026-08-06 · GB
- Rate decisionReserve Bank of Australia rate decision (press conf.)2026-08-12 · AU
- Rate decisionNorges Bank rate decision (press conf.)2026-08-20 · NO
- Rate decisionSveriges Riksbank rate decision (press conf.)2026-09-03 · SE
- Rate decisionBank of Canada rate decision (press conf.)2026-09-09 · CA
- Rate decisionEuropean Central Bank rate decision (press conf.)2026-09-10 · EU
- Macro & political
- ElectionSE Swedish Election2026-09-14 · SE
- ElectionUS U.S. Midterms2026-11-03 · US
- ElectionFR French Legislative2027-06-01 · FR
Pre-earnings brief
Modular Medical Inc (MODD.O) has recorded its first analysis, establishing a baseline for future monitoring with no prior data available for delta computation. This initial snapshot reveals a company with a minimal institutional footprint, characterized by zero analyst coverage, no index memberships, and an unreported officer count, alongside a total of three top holders. The most material development in this initial review is the addition of two new notable holders as of March 31, 2026. These entries, detected on June 20, 2026, represent the first recorded changes in ownership structure for the ticker, signaling early-stage accumulation or interest from specific investors. One new investor, identified by ID 486, acquired 1,865 shares valued at approximately $9,847, representing a negligible weight of 0.00000059% in their portfolio. A second investor, ID 499, added 623 shares valued at roughly $3,289, accounting for a similarly minute portfolio weight of 0.00000058%. These additions matter as they constitute the first visible institutional activity for Modular Medical, providing a starting point for tracking holder trends. However, the extremely small share counts and values suggest these are likely micro-investments or initial positions rather than significant strategic stakes, consistent with the company's current lack of broader market attention. [doc:modd.o-ha-financials]
Signals & dispatch
Composite-score breakdown
Synthesis
Modular Medical Inc (MODD.O) is a healthcare services and equipment company that operates within the medical equipment, supplies, and distribution industry. The firm primarily engages in the sale of medical products, focusing on capital equipment and consumables for healthcare providers. Modular Medical is headquartered in the United States and is listed on the NASDAQ stock exchange. Specific details regarding operating segments or geographic revenue breakdowns are not provided in the available data.
Modular Medical Inc has a strong liquidity position, with a current ratio of 6.66, indicating that it holds significantly more current assets than current liabilities. The company's cash and equivalents amount to $9.23 million, which is a substantial portion of its total assets of $13.81 million. The company's price-to-book ratio is 1.62, suggesting that the market values the company at a premium to its book value. However, the company has no long-term debt, and its debt-to-equity ratio is 0.0, indicating a conservative capital structure.
The company's profitability metrics are negative, with a return on equity of -37.11% and a return on assets of -31.01%, which are below the industry median for medical equipment and supplies companies. The operating income and net income are both negative, at -$4.32 million and -$4.28 million, respectively. The company's operating cash flow is also negative at -$13.95 million, indicating that it is not generating sufficient cash from operations to sustain its activities.
Modular Medical Inc's revenue is concentrated in a single business segment, as disclosed in its financial statements. The company does not provide detailed geographic revenue breakdowns, but its operations are primarily based in the United States. The lack of geographic diversification may expose the company to regional economic and regulatory risks.
The company's growth trajectory is uncertain, as it has not provided specific revenue growth projections for the current or next fiscal year. The company's free cash flow is negative at -$4.62 million, and its capital expenditures are -$1.70 million, indicating that it is not investing in new projects or expanding its operations. The company's shares outstanding are the same for both basic and diluted shares, at 5.41 million, suggesting that there is no significant dilution risk from stock options or convertible securities.
The company's risk assessment indicates a low level of liquidity and dilution risk, with no immediate filing-based flags detected. The company's liquidity position is strong, with a high current ratio and significant cash reserves. However, the company's negative operating and net income, along with its negative operating cash flow, may raise concerns about its long-term financial sustainability. The company has not made any recent public filings or disclosures that would indicate significant changes in its business or financial condition.
Modular Medical Inc (MODD.O) has recorded its first analysis, establishing a baseline for future monitoring with no prior data available for delta computation. This initial snapshot reveals a company with a minimal institutional footprint, characterized by zero analyst coverage, no index memberships, and an unreported officer count, alongside a total of three top holders. The most material development in this initial review is the addition of two new notable holders as of March 31, 2026. These entries, detected on June 20, 2026, represent the first recorded changes in ownership structure for the ticker, signaling early-stage accumulation or interest from specific investors. One new investor, identified by ID 486, acquired 1,865 shares valued at approximately $9,847, representing a negligible weight of 0.00000059% in their portfolio. A second investor, ID 499, added 623 shares valued at roughly $3,289, accounting for a similarly minute portfolio weight of 0.00000058%. These additions matter as they constitute the first visible institutional activity for Modular Medical, providing a starting point for tracking holder trends. However, the extremely small share counts and values suggest these are likely micro-investments or initial positions rather than significant strategic stakes, consistent with the company's current lack of broader market attention. [doc:modd.o-ha-financials]
- Modular Medical Inc has a strong liquidity position with a current ratio of 6.66 and $9.23 million in cash and equivalents.
- The company's profitability metrics are negative, with a return on equity of -37.11% and a return on assets of -31.01%.
- The company's revenue is concentrated in a single business segment, and it does not provide detailed geographic revenue breakdowns.
- The company's growth trajectory is uncertain, with no specific revenue growth projections provided for the current or next fiscal year.
- The company's risk assessment indicates a low level of liquidity and dilution risk, with no immediate filing-based flags detected.
Bull / Bear case
Generated · model-assistedIn focus — financials by report
Operating income −61,2% YoY; Net income −62,0% YoY.
- ▍Operating income −61,2% YoY
- ▍Net income −62,0% YoY
- ▍Free cash flow −51,1% YoY
Operating income −15,3% YoY; Net income −15,1% YoY.
- ▍Operating income −15,3% YoY
- ▍Net income −15,1% YoY
- ▍Free cash flow −20,1% YoY
Operating income -$4.9M.
- ▍Operating income -$4.9M
Operating income -$5.0M.
- ▍Operating income -$5.0M
Operating income -$4.2M.
- ▍Operating income -$4.2M
Operating income -$4.3M.
- ▍Operating income -$4.3M
Operating income −26,3% YoY; Net income −25,9% YoY.
- ▍Operating income −26,3% YoY
- ▍Net income −25,9% YoY
- ▍Free cash flow −22,0% YoY
Operating income +14,6% YoY; Net income +25,5% YoY.
- ▍Operating income +14,6% YoY
- ▍Net income +25,5% YoY
- ▍Free cash flow +17,3% YoY
Operating income −121,5% YoY; Net income −152,6% YoY.
- ▍Operating income −121,5% YoY
- ▍Net income −152,6% YoY
- ▍Free cash flow −151,7% YoY
Valuation TTM
Revenue by segment
Business relationships
Supply chain
Peer comparison
Market position
Stress test
Predictor forecast
Options
Short squeeze
Earnings-call key lines
Estimate revisions
consensus EPS · 26-week trendSell-side observations
Themes
ESG
Risk factors
- No immediate filing-based liquidity or dilution flags were detected.
Benchmarks vs cohort
Corporate actions / M&A
FX exposure
Comparable transactions
Derivatives & instruments
Derivative transactions
- Director · Option to purchase common stock → Common StockAcquired 250 @ $4,88grant · 2026-06-30
- Director · Option to purchase common stock → Common StockAcquired 250 @ $4,88grant · 2026-06-30
- Director · Option to purchase common stock → Common StockAcquired 250 @ $4,88grant · 2026-06-30
- Director · Option to purchase common stock → Common StockAcquired 250 @ $4,88grant · 2026-06-30
- Director, 10% owner · Option to purchase common stock → Common StockAcquired 62 @ $4,88grant · 2026-06-30
- Director, 10% owner · Option to purchase common stock → Common StockAcquired 250 @ $4,88grant · 2026-06-30
- Chief Operating Officer · Option to purchase common stock → Common StockAcquired 4 674 @ $3,46grant · 2026-05-14
- See Remarks · Option to purchase common stock → Common StockAcquired 11 218 @ $3,46grant · 2026-05-14
- Director · Option to purchase common stock → Common StockAcquired 250 @ $4,55grant · 2026-03-31
- Director · Option to purchase common stock → Common StockAcquired 250 @ $4,55grant · 2026-03-31
- Director · Option to purchase common stock → Common StockAcquired 250 @ $4,55grant · 2026-03-31
- Director, 10% owner · Option to purchase common stock → Common StockAcquired 250 @ $4,55grant · 2026-03-31
- Director, 10% owner · Option to purchase common stock → Common StockAcquired 62 @ $4,55grant · 2026-03-31
- Director · Option to purchase common stock → Common StockAcquired 250 @ $4,55grant · 2026-03-31
- Director · Option to purchase common stock → Common StockAcquired 7 500 @ $0,36grant · 2025-12-31
- Director · Option to purchase common stock → Common StockAcquired 7 500 @ $0,36grant · 2025-12-31
- Director · Option to purchase common stock → Common StockAcquired 7 500 @ $0,36grant · 2025-12-31
- Director, 10% owner · Option to purchase common stock → Common StockAcquired 1 875 @ $0,36grant · 2025-12-31
- Director, 10% owner · Option to purchase common stock → Common StockAcquired 7 500 @ $0,36grant · 2025-12-31
- Director · Option to purchase common stock → Common StockAcquired 7 500 @ $0,36grant · 2025-12-31
- Director · Warrants to purchase Common Stock → Common StockAcquired 30 000 @ $0,45grant · 2025-12-11
- Director · Warrants to purchase Common Stock → Common StockAcquired 11 000 @ $0,45grant · 2025-12-11
- Director · Option to purchase common stock → Common StockAcquired 7 500 @ $0,70grant · 2025-09-30
- Director · Option to purchase common stock → Common StockAcquired 7 500 @ $0,70grant · 2025-09-30
- Director, 10% owner · Option to purchase common stock → Common StockAcquired 7 500 @ $0,70grant · 2025-09-30
Actions
Ask Handelsavisen
- Market data
- Market data cache
- Issuer disclosures
- Public news
- Earnings transcripts
- Consensus estimates
- ESG data
- Return On Equitynet_income / total_equity
- Price To Bookmarket_price / (adjusted_book_value / shares_outstanding_diluted)
- Dilution Ratio(shares_outstanding_diluted - shares_outstanding_basic) / shares_outstanding_basic
- Market Priceinput from market-data provider (delayed close or quote-shim mid)
- Market Capmarket_price * shares_outstanding_diluted
- Net Cashcash_and_equivalents + short_term_investments - short_term_debt - long_term_debt
- Modular Medical Inc Market data — financials · 2026-05-28
Ownership & reference
Top holders
- Investment Managers · as of 2026-03-310,00 %$0M
- Investment Managers · as of 2026-03-310,00 %$0M
- Investment Managers · as of 2026-03-310,00 %$0M
Insider activity
- Director · Common StockOther 25 · 2026-06-30
- Director · Common stockOther 83 · 2026-06-30
- Director · Common StockOther 110 · 2026-06-30
- Director · Common StockOther 25 · 2026-03-31
- Director · Common stockOther 83 · 2026-03-31
- Director · Common StockOther 103 · 2026-03-31
- Director · Common StockOther 3 125 · 2025-12-31
- Director · Common stockOther 2 500 · 2025-12-31
- Director · Common StockOther 750 · 2025-12-31
- Director · Common StockOther 60 000 · 2025-12-11
- Director · Common StockOther 22 000 · 2025-12-11
- Director · Common StockOther 3 125 · 2025-09-30
- Director · Common StockOther 750 · 2025-09-30
- Director · Common stockOther 2 500 · 2025-09-30
Short positioning
Geographic breakdown
Intel & risk
Evidence & claims
From filings & derived data- EPS (basic) (annual): USD-PER-SHARES -12Unknown
- Net income (annual): USD -28.24MUnknown
- Total operating expenses (annual): USD 27.56MUnknown
- Operating cash flow (annual): USD -23.75MUnknown
- Operating income (annual): USD -27.56MUnknown
- R&D expense (annual): USD 19.97MUnknown
- EPS (diluted) (annual): USD-PER-SHARES -12Unknown
- Capex (annual): USD 3.93MUnknown
- Pre-tax income (annual): USD -28.24MUnknown
- Shareholders' equity (YoY) (2025-12-31 vs 2024-12-31): -42.7%Derived (calculated)
- Cash & equivalents (YoY) (2025-12-31 vs 2024-12-31): -58.0%Derived (calculated)
- Debt-to-equity (FY 2025-12-31): 0.74xDerived (calculated)
- Current ratio (FY 2025-12-31): 1.59xDerived (calculated)
- Total liabilities (YoY) (2025-12-31 vs 2024-12-31): 132.0%Derived (calculated)
- Total assets (YoY) (2025-12-31 vs 2024-12-31): -15.6%Derived (calculated)
- Total assets (annual): USD 10.26MSEC XBRL filing
- Shareholders' equity (annual): USD 5.88MSEC XBRL filing
- Cash & equivalents (annual): USD 2.94MSEC XBRL filing
- Current liabilities (annual): USD 2.18MSEC XBRL filing
- Current assets (annual): USD 3.47MSEC XBRL filing
- Total liabilities (annual): USD 4.38MSEC XBRL filing
- Shares outstanding (annual): 77.7MSEC XBRL filing
- Operating income (YoY) (2025-03-31 vs 2024-03-31): -8.7%Derived (calculated)
- Operating cash flow (YoY) (2025-03-31 vs 2024-03-31): -12.7%Derived (calculated)